Our results showed significantly higher levels of CD3/CD69-, CD8/CD69- and CD19/CD69-positive PBMCs as well as within CD3+ cells present in patients with psoriasis when compared to the healthy control group, which is in agreement with the above findings (Table 3). The gene discussed is CD69; the disease is psoriasis.